Skip to content

Application of variable rate feedback infusion vs common patient-controlled analgesia pump in postoperative analgesia after laparoscopic colorectal cancer surgery: a multicenter, prospective, randomized controlled study

Application of variable rate feedback infusion vs common patient-controlled analgesia pump in postoperative analgesia after laparoscopic colorectal cancer surgery: a multicenter, prospective, randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126356
Enrollment
Unknown
Registered
2026-06-08
Start date
2026-06-09
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Group C:Traditional PCA pump (fixed background dose infusion mode)
Group O:Variable rate feedback infusion mode PCA pump

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing laparoscopic radical resection of colorectal cancer under general anesthesia; 2. Aged 18-75 years, gender unlimited, 18.0 kg/m2 <= body mass index (BMI) <= 30.0kg/m2; 3. ASA I - ?; 4. Patients were treated with postoperative patient-controlled intravenous analgesia pump (PCIA); 5. The patients and their families gave informed consent.

Exclusion criteria

Exclusion criteria: 1. Diagnosed mental illness or preoperative inability to communicate due to cognitive impairment or language disorder; 2. Preoperative patients with severe cardiovascular, liver, kidney and other diseases: preoperative patients with severe cardiovascular diseases (such as sick sinus syndrome, high atrioventricular block without pacemaker, severe cardiac insufficiency NYHA ? - ?), or ALT or ast>2 times the upper limit of normal value, or creatinine>the upper limit of normal value, or received dialysis treatment within 28 days before operation; 3. Known allergic reactions to narcotic drugs; 4. Preoperative history of chronic pain or opioid abuse; 5.. Have a history of drug abuse and/or alcohol abuse in recent 3 months, i.e. drinking>2 units of alcohol per day on average (1 unit=360ml of beer with 5% alcohol or 45ml of liquor with 40% alcohol or 150ml of wine; 6. Conversion to laparotomy; 7. Postoperative admission to ICU; 8. Participated in clinical research of other drugs or medical devices in recent 3 months.

Design outcomes

Primary

MeasureTime frame
Opioid consumption;

Secondary

MeasureTime frame
PCA pump related indicators (Total compression times, effective compression times, etc);Pain assessment;Recovery Quality;Adverse Reaction;

Countries

China

Contacts

Public ContactYang Jiangjun

The First Affiliated Hospital of Zhengzhou University

jianjunyang1971@163.com+86 137 8353 7619

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026